Americans shouldn’t have to pay the highest prices in the world for the medicines they need. Minnesotans depend on their prescriptions – but from cancer treatments to EpiPens, and beyond, drug companies' skyrocketing prices are pushing life-saving treatments out of reach for those who need them. Medications don’t work if people can’t afford them. It's time to Stop Rx Greed.This year the Minnesota legislature could stand up to drug companies and pass legislation that will make medications more affordable. But they need to hear from you. Legislators are considering a bi-partisan bill that would establish an independent commission charged with ensuring that all drugs are affordable for Minnesotans. Tell your legislator today to stop letting drug companies price gouge seniors and taxpayers and pass bipartisan legislation to lower prescription drug prices.
AARP supports the development of a Minnesota state drug affordability review commission and believes that federal, state, and local governments should ensure that prescription drug launch prices and subsequent pricing decisions are reasonable, justified, and support improved consumer access and affordability. The Prescription Drug Commission has bi-partisan support in the Minnesota legislature (HF3228; Morrison/SF3120; Jensen).
A Prescription Drug Affordability Commission, based on a National Academy of State Health Policy (NASHP) model, is an independent body that evaluates drug prices and sets limits on how much certain payers, including state agencies, will pay for high-cost prescription medications. Maryland was the first state to pass a prescription drug affordability board in 2019 and Maine did as well.
This story is provided by AARP Minnesota. Visit the AARP Minnesota page for more news, events, and programs affecting retirement, health care, and more.
AARP will host a weekly live Coronavirus Information Tele-Town Hall on Thursday at 1 pm (ET). Please join us each week for the latest information on the Coronavirus.Read More »
JOIN FOR JUST $16 A YEAR